miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

Nintedanib (BIBF1120) is a multi-targeted angiokinase inhibitor and has been evaluated in idiopathic pulmonary fibrosis and advanced non-small cell lung cancer (NSCLC) patients in clinical studies. In the present study, we evaluated the antitumor effects of nintedanib in 16 NSCLC cell lines and trie...

Descripción completa

Detalles Bibliográficos
Autores principales: NISHIJIMA, NOBUHIKO, SEIKE, MASAHIRO, SOENO, CHIE, CHIBA, MIKA, MIYANAGA, AKIHIKO, NORO, RINTARO, SUGANO, TEPPEI, MATSUMOTO, MASARU, KUBOTA, KAORU, GEMMA, AKIHIKO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750530/
https://www.ncbi.nlm.nih.gov/pubmed/26783187
http://dx.doi.org/10.3892/ijo.2016.3331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750530/
https://www.ncbi.nlm.nih.gov/pubmed/26783187
http://dx.doi.org/10.3892/ijo.2016.3331

Ejemplares similares